An urgent need for a change in policy revealed by a study on prenatal testing for Duchenne muscular dystrophy

European Journal of Human Genetics

Volumn 21, Issue 1, 2013, Pages 21-26

  Helderman Van Den Enden, Apollonia T J M ^a,c   Madan, Kamlesh ^a   Breuning, Martijn H ^a   Van Der Hout, Annemieke H ^b   Bakker, Egbert ^a   De Die Smulders, Christine E M ^c   Ginjaar, Hendrika B ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

carrier testing; Duchenne muscular dystrophy; neonatal screening; preimplantation genetic diagnosis; prenatal diagnosis

Indexed keywords

ABORTION; ARTICLE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; FAMILY; FEMALE; FETUS; GENE MUTATION; GENETIC COUNSELING; GENETIC RISK; HEALTH CARE POLICY; HEART DISEASE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEWBORN SCREENING; PRENATAL SCREENING; PRIORITY JOURNAL; PROGENY;

DYSTROPHIN; FEMALE; GENETIC COUNSELING; HETEROZYGOTE; HUMANS; INCIDENCE; INFANT, NEWBORN; MALE; MUSCULAR DYSTROPHY, DUCHENNE; MUTATION; NEONATAL SCREENING; NETHERLANDS; PEDIGREE; PREGNANCY; PREIMPLANTATION DIAGNOSIS; PRENATAL DIAGNOSIS;

EID: 84871191322     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2012.101     Document Type: Article

References (28)

1. Magri F, Govoni A, D'Angelo MG et al: Genotype and phenotype characterization in a large dystrophinopathic cohort with extended follow-up. J Neurol 2011; 258: 1610-1623.
2. Emery AE: Population frequencies of inherited neuromuscular diseases: a world survey Neuromuscul Disord 1991; 1: 19-29.
3. Haldane JBS: The rate of spontaneous mutation of a human gene. J Genet 1935; 31: 317-326.
4. Bakker E, Hofker MH, Goor N et al: Prenatal diagnosis and carrier detection of Duchenne muscular dystrophy with closely linked RFLPs. Lancet 1985; 1: 655-658.
5. de Die-Smulders CE, Geraedts JP, Dreesen JC, Coonen E, Land JA: Genetic diagnosis of IVF embryos: preliminary results from 'preimplantation genetic diagnoses' in the Netherlands. Ned Tijdschr Geneeskd 1998; 142: 2441-2444.
6. Almomani R, van der SN, Bakker E, den Dunnen JT, Breuning MH, Ginjaar IB: Rapid and cost effective detection of small mutations in the DMD gene by high resolution melting curve analysis. Neuromuscul Disord 2009; 19: 383-390.
7. van Essen AJ, Busch HF, te Meerman GJ, Ten Kate LP: Birth and population prevalence of Duchenne muscular dystrophy in The Netherlands. Hum Genet 1992; 88: 258-266.
8. Helderman-van den Enden AT, de Jong R, den Dunnen JT et al: Recurrence risk due to germ line mosaicism: Duchenne and Becker muscular dystrophy. Clin Genet 2009; 75: 465-472.
9. Dooley J, Gordon KE, Dodds L, MacSween J: Duchenne muscular dystrophy: a 30-year population-based incidence study. Clin Pediatr 2010; 49: 177-179.
10. Jeppesen J, Green A, Steffensen BF, Rahbek J: The Duchenne muscular dystrophy population in Denmark, 1977-2001: prevalence, incidence and survival in relation to the introduction of ventilator use. Neuromuscul Disord 2003; 13: 804-812.
11. Taylor PJ: Molecular genetic analysis of a New South Wales muscular dystrophy cohort. Dissertation 2008; http://handle.unsw.edu.au/1959.4/43309.
12. Hildes E, Jacobs HK, Cameron A et al: Impact of genetic counselling after neonatal screening for Duchenne muscular dystrophy. J Med Genet 1993; 30: 670-674.
13. Bradley D, Parsons E: Newborn screening for Duchenne muscular dystrophy. Semin Neonatol 1998; 3: 27-34.
14. Drousiotou A, Ioannou P, Georgiou T et al: Neonatal screening for Duchenne muscular dystrophy: a novel semiquantitative application of the bioluminescence test for creatine kinase in a pilot national program in Cyprus. Genet Test 1998; 2: 55-60.
15. Eilers R, Kleinveld JH, Vroom E, Westerman MJ, Cornel MC, Plass AC: Desirability of early identification of Duchenne Muscular Dystrophy (DMD): parents' experiences of the period prior to diagnosis. Eur J Hum Genet 2009; 18(supp 1): 374-375.
16. Borry P, Evers-Kiebooms G, Cornel MC, Clarke A, Dierickx K: Genetic testing in asymptomatic minors: background considerations towards ESHG recommendations. Eur J Hum Genet 2009; 17: 711-719.
17. Abbs S, Tuffery-Giraud S, Bakker E, Ferlini A, Sejersen T, Mueller CR: Best practice guidelines on molecular diagnostics in Duchenne/Becker muscular dystrophies. Neuromuscul Disord 2010; 20: 422-427.
18. Bushby K, Muntoni F, Bourke JP: 107th ENMC International Workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands. Neuromuscul Disord 2003; 13: 166-172.
19. Hoogerwaard EM, van der Wouw PA, Wilde AA et al: Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy. Neuromuscul Disord 1999; 9: 347-351.
20. van Westrum SM, Hoogerwaard EM, Dekker L et al: Cardiac abnormalities in a follow-up study on carriers of Duchenne and Becker muscular dystrophy. Neurology 2011; 77: 62-66.
21. Davies JE, Winokur TS, Aaron MF, Benza RL, Foley BA, Holman WL: Cardiomyopathy in a carrier of Duchenne's muscular dystrophy. J Heart Lung Transplant 2001; 20: 781-784.
22. Kerzin-Storrar L, Wright C, Williamson PR et al: Comparison of genetic services with and without genetic registers: access and attitudes to genetic counselling services among relatives of genetic clinic patients. J Med Genet 2002; 39: e85.
23. Plumridge G, Metcalfe A, Coad J, Gill P: Family communication about genetic risk information: particular issues for Duchenne muscular dystrophy. Am J Med Genet A 2010; 152A: 1225-1232.
24. Lo YM, Chan KC, Sun H et al: Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med 2010; 2: 61ra91.
25. Bell CJ, Dinwiddie DL, Miller NA et al: Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med 2011; 3: 65ra4.
26. Aartsma-Rus A: Antisense-mediated modulation of splicing: therapeutic implications for Duchenne muscular dystrophy. RNA Biol 2010; 7: 453-461.
27. Goemans NM, Tulinius M, van den Akker JT et al: Systemic administration of PRO051 in Duchenne's muscular dystrophy. N Engl J Med 2011; 364: 1513-1522.
28. Van Deutekom JC, Janson AA, Ginjaar HB et al: Local dystrophin restoration with antisense oligonucleotide PRO051. N Engl J Med 2007; 357: 2677-2686.